Literature DB >> 23095881

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Therese A Dolecek, Jennifer M Propp, Nancy E Stroup, Carol Kruchko.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23095881      PMCID： PMC3480240          DOI： 10.1093/neuonc/nos218

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries.

Authors:  Nadia Howlader; Lynn A Ries; David G Stinchcomb; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

2.  International Classification of Childhood Cancer, third edition.

Authors:  Eva Steliarova-Foucher; Charles Stiller; Brigitte Lacour; Peter Kaatsch
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 3.  Consensus Conference on Brain Tumor Definition for registration. November 10, 2000.

Authors:  Bridget J McCarthy; Tanya Surawicz; Janet M Bruner; Carol Kruchko; Faith Davis
Journal:  Neuro Oncol       Date:  2002-04       Impact factor: 12.300

4.  Factors associated with survival in patients with meningioma.

Authors:  B J McCarthy; F G Davis; S Freels; T S Surawicz; D M Damek; J Grutsch; H R Menck; E R Laws
Journal:  J Neurosurg       Date:  1998-05       Impact factor: 5.115

5.  Impact of reporting delay and reporting error on cancer incidence rates and trends.

Authors:  Limin X Clegg; Eric J Feuer; Douglas N Midthune; Michael P Fay; Benjamin F Hankey
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

6.  Efficient interval estimation for age-adjusted cancer rates.

Authors:  Ram C Tiwari; Limin X Clegg; Zhaohui Zou
Journal:  Stat Methods Med Res       Date:  2006-12       Impact factor: 3.021

7.  Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article.

Authors:  Kevin S Cahill; Elizabeth B Claus
Journal:  J Neurosurg       Date:  2011-04-29       Impact factor: 5.115

Review 8.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088
  9 in total
  700 in total

1.  Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.

Authors:  Tosol Yu; Hyun-Cheol Kang; Do Hoon Lim; Il Han Kim; Woong-Ki Chung; Chang-Ok Suh; Byung Ock Choi; Kwan Ho Cho; Jae Ho Cho; Jin Hee Kim; Chul-Kee Park; Yong-Kil Hong; In Ah Kim
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

Review 2.  Recent advances in intradural spinal tumors.

Authors:  Muhammad M Abd-El-Barr; Kevin T Huang; Ziev B Moses; J Bryan Iorgulescu; John H Chi
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

3.  MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.

Authors:  Dong Wang; Tongle Zhi; Xiupeng Xu; Zhongyuan Bao; Liang Fan; Zheng Li; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.

Authors:  Priya Kumthekar; Sean Grimm; James Chandler; Minesh Mehta; Maryanne Marymont; Robert Levy; Kenji Muro; Irene Helenowski; Katie McCarthy; Leanne Fountas; Jeffrey Raizer
Journal:  J Neurooncol       Date:  2017-05-16       Impact factor: 4.130

Review 5.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

Review 6.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

7.  Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.

Authors:  Hao You; Yao Wu; Kai Chang; Xiao Shi; Xin-Da Chen; Wei Yan; Rui Li
Journal:  CNS Neurosci Ther       Date:  2017-09-03       Impact factor: 5.243

8.  Neuroimaging diagnosis of pineal region tumors-quest for pathognomonic finding of germinoma.

Authors:  Ryuji Awa; Francia Campos; Kazunori Arita; Kazuhiko Sugiyama; Atsushi Tominaga; Kaoru Kurisu; Fumiyuki Yamasaki; Prasanna Karki; Hiroshi Tokimura; Yoshihiko Fukukura; Yukihiko Fujii; Ryosuke Hanaya; Tatsuki Oyoshi; Hirofumi Hirano
Journal:  Neuroradiology       Date:  2014-04-29       Impact factor: 2.804

9.  Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10.

Authors:  Matthew J Oborski; Charles M Laymon; Yongxian Qian; Frank S Lieberman; Arden D Nelson; James M Mountz
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.